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Abstract: Proteins are prone to inactivation in aqueous solutions because chemical modification and 
aggregation usually occur, particularly at high temperature. This review focuses on the recent advance 
in practical application with amine compounds that prevent the heat-induced inactivation and aggrega-
tion of proteins. Coexistence of amine solutes, typically diamines, polyamines, amino acid esters, and 
amidated amino acids decreases the heat-induced inactivation rate of proteins by one order of magni-
tude compared with that in the absence of additives under low concentrations of proteins at physiological pH. The amine 
compounds mainly suppress chemical modification, typically the β-elimination of disulfide bond and deamidation of as-
paragine side chain, thereby preventing heat-induced inactivation of proteins. Polyamines do not improve the refolding 
yield of proteins, owing to decrease in the solubility of unfolded proteins. In contrast, arginine is the most versatile addi-
tive for various situations, such as refolding of recombinant proteins, solubilized water-insoluble compounds, and preven-
tion of nonspecific binding to solid surfaces; however, it is not always effective for preventing heat-induced aggregation. 
Amine compounds will be a key to prevent protein inactivation in solution additives. 
Keywords: Amine compound, arginine, polyamine, amino acid derivative, protein aggregation, protein inactivation, solvent 
additive. 
1. INTRODUCTION 
 Proteins are unstable in aqueous solution. The instability 
of proteins poses a serious problem for their application in 
purification, shipping, storage, and handling. The causes of 
protein inactivation can be classified into physical and 
chemical processes; the former involves structural unfolding 
and aggregation, whereas the latter involves chemical modi-
fication [1]. Various kinds of low molecular weight additives 
have been developed to avoid protein inactivation and ag-
gregation [2]. 
 This review focuses on the amine compounds that pre-
vent the heat-induced inactivation and aggregation of pro-
teins as solvent additives and provides the following infor-
mation: 1) We summarize a systematic property of amine 
compounds that prevents the heat-induced inactivation and 
aggregation of proteins, such as amino acids, amino acid 
alkylesters, amidated amino acids, diamines, and naturally 
occurring polyamines; 2) We introduce the major causes for 
chemical modifications of proteins, deamidation of Asn resi-
due, β-elimination of disulfide bond, and disulfide exchange; 
3) We describe the prevention of such chemical modification 
by amine compounds from heat treatment. The inhibition  
of chemical modifications results in the prevention of heat-
induced inactivation of proteins; 4) We introduce the most 
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well-known additive Arg. Arginine prevents the heat-induced 
aggregation of proteins as well as increases the solubility of 
aromatic compounds and aggregation-prone unfolded pro-
teins; 5) We discuss the additives regarding the distinction 
between heat-induced aggregation and refolding-induced 
misfolding. Finally, we discuss why amine compounds  
from living cells prevent the heat-induced degradation of 
proteins.  
1.1. Amine Compound Prevents Heat-induced Inactiva-
tion and Aggregation of Proteins 
 Several studies have reported on amine compounds as 
solvent additives for the prevention of heat-induced inactiva-
tion and aggregation under similar conditions, namely heat 
treatment at 98°C at neutral pH (pH 6.5-7.5) and relatively 
low protein concentration (0.2-1.0 mg/ml) for model proteins 
such as hen egg white lysozyme and bovine ribonuclease A 
(RNase A). The chemical structures of the reported amine 
additives and related compounds are shown in (Fig. 1). It 
should be noted that additives that prevent heat-induced in-
activation and aggregation have amine groups. Firstly, we 
briefly summarize the existing data of heat-induced inactiva-
tion and aggregation with additives as follows: 
 i) Arg achieves a stronger effect in preventing the heat-
induced aggregation of proteins than the other naturally-
occurring amino acids for lysozyme and other model pro-
teins such as Candida rugosa lipase, bovine trypsin, bovine 
α-chymotrypsinogen, bovine RNase A, horse myoglobin, 
1873-4316/16 $58.00+.00 © 2016 Bentham Science Publishers  
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bovine cytochrome c, and concanavalin A [3]. The additives 
were used at 0.2 M and 0.5 M. Arg has commonly been used 
as a protein refolding additive since a quarter of a century 
[4]; however, Shiraki et al. pointed out a new application of 
Arg as additive that prevents the heat-induced aggregation of 
proteins [3]. 
 
 
 
Fig. (1). List for the chemical structures of additives. Gdn (gua-
nidine hydrochloride), Arg (arginine), ArgEE (arginine ethylester), 
Lys (lysine), Gly (glycine), GlyEE (glycine ethylester), GlyAd 
(glycine amide), HArg (homo-arginine), AGPA (2-amino-3-
propionic acid), and DAC (1,2-diaminocyclohexane). 
 
 ii) Arg ethylester (ArgEE) was more effective in prevent-
ing both the heat-induced inactivation and aggregation of 
lysozyme than Arg [5]. Heat-induced inactivation and aggre-
gation of 1.0 mg/ml lysozyme at pH 7.1 was apparently a 
single-exponential process even in the absence and presence 
of additives; the rate constants of heat-induced inactivation 
were 7.0 × 10−3 s-1 (no additive), 4.2 × 10−3 s-1 (in 0.1 M 
Arg), and 1.2 × 10−3 s-1 (in 0.1 M ArgEE). The inactivation 
results from both irreversible unfolding of the tertiary struc-
ture and chemical modification on the catalytic site, though 
the cited study shows the difference in the inactivation rate 
without further discussion. 
 iii) It was serendipitously found that all varieties of 
amino acid alkylesters, as well as ArgEE, prevented both 
heat-induced inactivation and aggregation of lysozyme more 
effectively than amino acids themselves [6]. Glycine ethyles-
ter (GlyEE) was more effective in the heat-induced inactiva-
tion and aggregation of lysozyme than ethylene glycol 
monoester, guanidine, and Gly. Similarly, amidated amino 
acids, including glycineamide (GlyAd), prevented the heat-
induced inactivation and aggregation of lysozyme [7]. These 
data indicate that the modification of the carboxyl group of 
the amino acids is favorable for the heat-induced degradation 
of proteins.  
 iv) Arg derivatives (homo-arginine, Arg amide, and  
2-amino-3-guanidinopropionic acid) increased the refolding 
yield of lysozyme from a reduced and denatured state com-
pared to Arg [8]. A comparative analysis of amino acid de-
rivatives as co-solutes revealed that amino acid alkylesters 
and amidated amino acids act as favorable additives for pre-
venting the heat-induced degradation of proteins [9], while 
Arg derivatives are favorable for increasing the refolding 
yield of lysozyme. It is interesting that heat-induced inactiva-
tion is a different mechanism from the refolding-induced 
misfolding. This viewpoint will be discussed later. 
 v) Linear aliphatic diamines (1,3-diaminopropane, 1,4-
diaminobutane, and 1,5-diaminopentane) at 0.1 M prevented 
the heat-induced inactivation and aggregation of 0.2 mg/ml 
lysozyme [10]. Note that the diols (i.e., 1,3-propanediol, 1,4-
butanediol, and 1,5-pentanediol) did not prevent the heat-
induced inactivation and aggregation of lysozyme. Arrhenius 
plots showed linear correlation between the temperature of 
the heat treatment and residual activity after the heat treat-
ment in the presence or absence of diamines [10], meaning 
that a dominant single rate-limiting step controls the early 
stage of the heat-induced inactivation of lysozyme, which is 
possibly a chemical modification.  
 vi) Other amine compounds, such as the naturally-
occurring polyamines of putrescine, spermidine, and sper-
mine [11], and the synthetic compounds of 1,2-
diaminocyclohexane, 1,3-diaminocyclohexane, and 1,4-
diaminocyclohexane [12] were found to be superior suppres-
sors of the heat-induced inactivation and aggregation of 
lysozyme and RNase A. The rate constants of heat-induced 
inactivation and aggregation at 98°C of lysozyme were one 
order of magnitude higher than those in the presence of 0.1 
M diamines. The pH-dependent experiment showed that the 
charged state of diamines plays an important role for the 
prevention of thermal degradation [12].  
 vii) Inorganic ammonium salts prevented heat-induced 
aggregation more effectively than sodium salts [13]. For 
example, 0.6 M NH4Cl and (NH4)2SO4 as co-solutes de-
creased the aggregation rate of lysozyme by one-order mag-
nitude compared with NaCl and Na2SO4. Aggregation rates 
of lysozyme in various salts were in good correlation with 
the molar surface tension increment of solvents, except for 
ammonium salts; thus, it was concluded that ammonium 
salts possess a function that prevents the thermal aggregation 
of proteins, rather than surface tension with the Hofmeister 
effect. 
 The above-mentioned data indicate that amine com-
pounds, including ammonium ions, prevent the heat-induced 
inactivation and aggregation of proteins. As described below, 
the molecular mechanisms of the amine compounds acting as 
additive are mainly triggered by the prevention of chemical 
modifications, which would lead to the prevention of the 
irreversible inactivation of proteins. 
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1.2. Chemical Modifications of Protein by Heat Treat-
ment 
 Chemical modifications of protein by heat treatment have 
been well documented during the 1980s. Dr. Klivanov et al. 
examined the chemical modifications of hen egg white 
lysozyme and bovine RNase A as models when treated at 
high temperature [14-17]. As shown in (Fig. 2), the chemical 
modifications of proteins were classified into five kinds: 1) 
deamidation of Asn and Gln side chains; 2) β-elimination of 
disulfide bond; 3) disulfide bond exchange of Cys; 4) oxida-
tion of Met and Cys side chains; and 5) hydrolysis of the 
peptide bond with Asp. 
 Deamidation of the side chains of Asn and Gln (Fig. 2A) 
frequently occurs among chemical modifications at broad pH 
ranges [18, 19], which is one of the main problems hamper-
ing the production of pharmaceutical antibody byproducts 
[20] and sample preparation for mass spectroscopy [21]. The 
molecular mechanism of deamidation was well investigated 
using a hexapeptide as a model [22]. Under the neutral or 
weak alkaline pH (typically pH 7-11), peptide deamidation 
occurs via a cyclic imide intermediate, while under the acidic 
pH, the Asn side chain directly undergoes hydrolysis. The 
deamidation rate of Asn is one order of magnitude faster 
than that of Gln. 
 Disulfide bond-linked Cys side chains stabilize the ther-
modynamic structure of the native state by decreasing the 
conformation entropy of the unfolded state. However, the 
disulfide bond is prone to cause β-elimination (Fig. 2B) from 
neutral to alkaline pH ranges [16], such as monoclonal anti-
body during storage [23] and sample preparation for mass 
spectroscopy [24]. The occurrence of β-elimination triggered 
the deprotonation of Cα-H bonds by base catalyst, followed 
by the formation of thiocysteine and dehydroalanine [25]. 
Thiocysteine further degrades other sulfur compounds. Sub-
sequently, the product dehydroalanine is prone to link with 
the Lys side chain.  
 The thiolate ion on Cys side-chain is an active nucleo-
phile; thus, the sulfur atom of the dislfide bond is subjected 
to nucleophilic attack by thiolate ion. The disulfide bond 
exchange also occurs under a high concentration of protein at 
weak alkaline pHs [26, 27]. Such disulfide bond exchange 
causes protein aggregation by intermolecular cross-linking 
under high concentrations of proteins (> 1 mg/ml) around 
weak alkaline pH (around approximately the isoelectric point 
of the thiol side chain, pH 8.2). 
 Other chemical reactions are also known; the oxidation of 
sulfur containing amino acids (Met and Cys) (Fig. 2C) and 
hydrolysis of peptide bond occur during heat treatment in 
aqueous solutions. Met and Cys in polypeptide are oxidized 
in aqueous solution [28, 29]. The C-terminus of Asp residue 
is prone to hydrolyze under weak-acidic condition [30].  
 The main causes of chemical modification at approxi-
mately neutral pHs at high temperature are deamidation,  
β-elimination, and disulfide exchange. As described below, 
β-elimination and deamidation are dominant causes at low 
protein concentration (typically < 1.0 mg/ml), while disul-
fide bond exchange is the dominant cause with increasing 
concentrations of proteins. The practical application of 
amine compounds as additives that prevents such chemical 
modifications is described below. 
 
 
Fig. (2). Main chemical modifications of proteins in aqueous solution. (A) Deamidation of the Asn side chain via a cyclic imide intermediate. 
(B) β-elimination of the disulfide bond. (C) Oxidation of Met and Cys side chains. 
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1.3. Amine Compounds Prevent β-elimination of the  
Disulfide Bond and Deamidation of the Asn Side Chain 
 To investigate amine co-solutes in general, inactivation 
rates were compared with lysozyme and RNase A in the 
presence of eight kinds of additives, namely Arg, Gly, Lys, 
guanidine (Gdn), GlyAd, spermidine, NaCl, and NH4Cl [31]. 
The half-life time of the enzyme activity (τ1) treated at 98°C 
was 3.6 min under the condition at 1.0 mg/ml RNase A in 50 
mM Na–phosphate buffer (pH 7.0; Fig. 3A). In the presence 
of additives, the τ1 values varied from 4.5 min (NaCl) to 41.1 
min (GlyAd). As expected, the order is similar to that previ-
ously reported; amine compounds decreased the inactivation 
rate of the enzyme. GlyAd was the most favorable additive 
to prevent the heat-induced inactivation of both enzymes; the 
order of the effects of additives was GlyAd > spermidine > 
NH4Cl > Arg = Lys > Gly = Gdn = NaCl. A similar order 
was obtained for the inactivation rate of lysozyme from 2.6 
min (Gdn) to 19.5 min (GlyAd). 
 From the results, it was concluded that the suppressive 
effects of additives for heat-induced inactivation are because 
of their abilities to suppress the intrinsic chemical modifica-
tions of proteins. The most important point is the clear corre-
lation between the inactivation rate of RNase A and 
lysozyme with the correlation coefficient of 0.98 in the pres-
ence of eight kinds of additives (Fig. 3B). Moreover, the 
deamidation rate of the Asn side chain of RNase A and 
lysozyme decreased in the order GlyAd > spermidine > Lys 
> Arg, which is correlated to the inactivation rate of both 
proteins in the presence of these additives (Fig. 3C). Simi-
larly, the β-elimination of the proteins decreased in the  
almost same order (Fig. 3D). Thus, these results indicate that 
amine compounds prevent the chemical modifications such 
as deamidation and β-elimination, leading to the prevention 
of thermal degradation of proteins.  
 In addition, the question of why amine co-solutes prevent 
such chemical modifications of proteins is interesting. 
Amine compounds are also cations; for example, polyamines 
 
 
Fig. (3). Thermal inactivation of RNase A and lysozyme in the presence of additives. The protein of 1.0 mg/ml with 200 mM additives and 
50 mM Na-phosphate (pH 7.0) were heated at 98°C, and then the residual activity, deamidation, and β-elimination were determined. (A) The 
residual activity of RNase A after the heat treatment at respective time. The value of τ1 is defined as the half-life time of the residual activity 
of enzyme. (B) The correlation between τ1 of RNase A and τ1 of lysozyme after the heat treatment in the presence of additives. (C) The cor-
relation between τ1 and the time for deamidation of one Asn residue per a protein (τ2) of RNase A after the heat treatment in the presence of 
additives. (D) The correlation between τ1 and the time for β-elimination of 0.2 disulfide bond per a protein (τ3) of RNase A after the heat 
treatment in the presence of additives. The r values in figures are correlation coefficients. The raw data were obtained from a previous study 
[31].	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interact with the negatively charged region on proteins as a 
polycation that may protect the chemical modification. How-
ever, the binding between proteins and small amine com-
pounds is too weak to identify the binding assay by surface 
plasmon resonance (SPR) and the structural biology by x-ray 
crystallography and nuclear magnetic resonance (NMR). 
Molecular dynamics simulation suggests weak binding be-
tween the enzyme chymotrypsin and polyamines [32]. Thus, 
in the future, the precise chemical mechanism may be de-
scribed by quantum mechanics by calculation combined with 
various spectroscopic techniques. 
 From an industrial and experimental application point of 
view, 50-100 mM GlyAd or polyamine is recommended as 
an additive in protein solution when the prevention of 
chemical degradation and protein inactivation during storage 
and shipping at high temperature is preferred. NH4Cl will be 
required at high concentration, such as 500 mM. In addition, 
Arg at 100-500 mM is a good condition for a solution when 
noncovalent interactions between proteins and/or proteins 
and solid surfaces are the driving force for the inactivation 
and aggregation of the proteins, as described below. 
1.4. Arginine is a Versatile Additive that Prevents Physi-
cal Aggregation Rather than Chemical Inactivation 
 Arg is currently a well-known additive within biotech-
nology and pharmaceutics, as demonstrated in a comprehen-
sive review by Dr. Arakawa and co-worker [33]. Arg as an 
additive appeared for the first time in the application of the 
refolding method on recombinant proteins. During the 1980s, 
Dr. Rudolph discovered Arg as a refolding additive on the 
recombinant full-length tissue-type plasminogen activator, as 
described in a well-documented review article for refolding 
of recombinant proteins [34], fab-fragment refolding [35], 
and suppression of aggregation [36]. The pioneering work 
using Arg as an additive outlined the refolding of a recombi-
nant Fab-fragment from the inclusion body to the native state 
[4]. After the discovery, Arg has been use for the refolding 
of many medical proteins, including immunotoxin from 
monoclonal antibody fused with Pseudomonas exotoxin A 
[37], truncated tissue-type plasminogen activator [38], rabbit 
heterotetrameric casein kinase II [39], interleukin-6 receptor 
[40], Psedomonas fluorescens lipase [41], human neurotro-
phin-3 [42], human and mouse single-chain Fv fragments 
[43], human interleukin-21 [44], and human interleukin-10 
[45]. Furthermore, Arg-assisted refolding technology has 
been practically enhanced for “step-wise dilution” [46], the 
synergistic effect of Arg with kosmotropic ions [47] or a 
weak detergent of lauroyl-L-glutamate and Arg [48] and on 
the column refolding of a monomeric noncollagenous do-
main of Type IV collagen [49]. 
 It has been pointed for over two decades that the gua-
nidino group of Arg stacks parallel with aromatic side chains 
[50], although the aromatic group is prone to being bound to 
the amino group [51] and cation [52]. Moreover, Arg in-
creases peptide and protein solubility, such as an aromatic-
rich insulin segment of FFYTP [53], gluten [54], reduced 
carboxymethyl lysozyme [9], and porcine myosin [55], sev-
eral times higher than those in the absence of any additives. 
Thermodynamic analyses revealed that Arg does not de-
crease the melting temperature of lysozyme as a model pro-
tein [3, 5]. Arg is not a protein denaturant; however, it per-
turbs local structure around the aromatic amino acid of pro-
teins [56, 57]. Moreover, x-ray crystallographic analyzes of 
hen egg lysozyme showed that three Arg molecules as addi-
tives are observed on an aromatic surface [58] and hydration 
water molecules are increased with increasing concentration 
of Arg molecules [59].  
 A quantitative experiment showed the transfer free ener-
gies from water to 1.0 M Arg solution of small aromatic 
compounds; coumarin was 2 kJ/mol [60]; the nucleobases 
adenine, guanine, cytosine, thymine, and uracil were 1–2 
kJ/mol [61-63]; alkyl gallates were 3 kJ/mol [64]; caffeic 
acid was 5 kJ/mol [65]. These data showed that Arg in-
creases the solubility of aromatic compounds, resulting from 
cation-π noncovalent interaction. The molecular mechanism 
of Arg as an additive is briefly summarized as follows:  
 i) Prevention of chemical modification. In addition, Arg 
prevents the heat-induced chemical modifications of pro-
teins, as described in the current review. However, the pre-
ventive effect of Arg on chemical modification is not ex-
traordinary but normal, as shown in (Fig. 3). 
 ii) Gap effect. The chemically inactive molecule of neu-
tral crowder increased the activation energy for association 
between proteins, leading to a decrease in the binding en-
ergy. The “gap theory” is favorably described by the Arg 
function on macromolecules [66, 67], α-chymotrypsinogen 
A, and melittin [68]. Various sizes of self-associated Arg 
molecules may function as crowders to prevent protein ag-
gregation [69]. 
 iii) Specific interaction. Cation-π interaction of the amino 
acid residues is commonly observed in a protein tertiary 
structure and protein interface [70, 71]. Similarly, Arg mole-
cules bind to proteins [58] and small compounds [61] with 
cation- π interaction. In addition, electrostatic interaction and 
hydrogen bonds occur. A cationic guanidium group can bind 
to an anion. Moreover, the binding free energy of the ion-
pair between guanidium and phosphate are −4.1 kJ/mol from 
theoretical computational calculation [72] and −2.4 kJ/mol 
from experimental work [73]. Such enthalpic binding may 
promote aggregation, while guanidine–aromatic interaction 
solubilizes proteins [74]. 
 iv) Solvent effect. It is to be noted that amino acids are 
preferentially excluded from protein surfaces [75], leading to 
the stabilization of the folded and compact state of proteins 
[76, 77]. Arg also increases the surface tension of water [78]; 
hence, Arg is basically excluded from protein surfaces. Thus, 
it may be concluded that Arg molecules bind to the protein 
surface with very low energy derived from cation-π and 
other specific interactions. In other words, this marginal ef-
fect of Arg additive on protein structures results in an out-
standing versatility for troublesome protein solutions in any 
situations. 
 v) Salt effect. Arg often uses at neutral pHs in buffer so-
lution. Arg solution is prepared by dissolution of the powder 
of arginine monohydrochloride (ArgHCl) or Arg base into 
buffer solution, followed by pH is adjusted with NaOH or 
HCl toward the desired neutral pH. Accordingly, the Arg 
solution is a kind of salts solution. Actually, Arg and Lys 
decrease the viscosity of high concentration of bovine (275 
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mg/ml) and human (305 mg/ml) serum albumin solutions as 
similar extent to the NaCl and guanidine hydrochloride solu-
tions [79]. The decrease in viscosity results from the salt 
effect that decreases the repulsion between high concentra-
tion albumins. It is noted that ArgHCl specifically decreases 
the viscosities of high concentration of gamma globulins 
from human and bovine among amino acids and salts, in-
cluding lysine hydrochloride and NaCl [80]. Taken together, 
Arg solution decreases the protein viscosity both salt effect 
and Arg-specific interaction effects. 
 These complex mechanisms of Arg with chemical reac-
tion, specific interaction, and bulk effect result in the contro-
versial appearance as a solvent additive that prevents the 
thermal aggregation of proteins [33]. For example, Arg did 
not prevent the heat-induced aggregation of human growth 
hormones and interferon-α2b [81] because Arg at low con-
centration (< 0.1 M) promotes aggregation by the suppres-
sion of electrostatic repulsion as salt effect. Similarly, Arg 
promotes heat-induced aggregation for the large immuno-
globulin G1 protein [82] and the β-lactoglobulin (βLG) oli-
gomeric protein [74]. Such structurally unstable proteins can 
be stabilized by the use of Arg with the acidic amino acids 
Glu and Asp [82] and the kosmotropic ions [47]. Thus, it is 
possible that Arg promotes the heat-induced aggregation of 
large and complex proteins at low concentration. It is noted 
that Arg does not prevent amyloid-like fibril aggregation of 
hen egg lysozyme induced by heat treatment at acidic pH 
[83]. The difference between thermal aggregation and amy-
loid fibrillization will be a key to understand the molecular 
mechanism of Arg on protein aggregation. 
1.5. Difference between Heat-induced Degradation and 
Refolding-induced Misfolding 
 A deeper examination of the molecular mechanism of 
additives could facilitate a discussion of the difference be-
tween refolding-induced misfolding and heat-induced degra-
dation. Figure 4 shows a simple scheme of protein refolding. 
Recombinant proteins usually form inclusion bodies (insolu-
ble and inactive aggregates) when expressed in host cells. 
Thus, the refolding is an indispensable process necessary to 
recover the native-state protein from the inclusion body. 
Firstly, the inclusion body should be solubilized using a re-
ducing reagent (ex. dithiothreitol, 2-mercaptoethanol, or glu-
tathione) with a high concentration of a denaturant (ex. 
GdnHCl or urea). Then, the reduced and unfolded state pro-
tein (UR) is diluted into a large amount of buffer. During this 
step, some proteins refold spontaneously into its native struc-
ture according to Anfinsen’s thermodynamic dogma (process 
(2) in Fig. 4), while the others form amorphous aggregates 
(process (3) in Fig. 4).  
 To increase the refolding yield of proteins, various tech-
niques have been developed. The early stage of the refolding 
methods has been well documented by Dr. Rudolph [34, 35] 
and Dr. Clark [84, 85]. The fundamental approach to increas-
ing the refolding yield of proteins is to decrease the irre-
versible aggregation. For example, the denaturant of urea is 
gradually removed by controlled dialysis [86]; detergent 
solubilizes the aggregation-prone folding intermediate, and 
then the detergent is stripped off the protein surface, so 
called “artificial chaperones” [87]; nano-scale pore isolates 
the aggregation-prone folding intermediate, followed by the 
controlled release by polyethylene glycol, which leads to a 
decrease in the probability of aggregation [88]. During the 
dilution step of the denaturant, the addition of 0.2-1.0 M Arg 
can prevent protein aggregation [89]. Arg is substituted for 
diluted denaturant that prevents intermolecular interaction 
between aggregation-prone folding and the intermediate state 
of proteins.  
 
 
 
Fig. (4). Refolding process from the inclusion body (IB) of a re-
combinant protein. (1) The recombinant protein of the inclusion 
body is solubilized by the reducing reagent and a high concentra-
tion of denaturant. Following this, (2) the reduced and unfolded 
protein (UR) is refolded to the native state (N) by various refolding 
methods. However, (3) the refolding process competes with aggre-
gation (A). The refolding process of (2) is basically spontaneous 
folding; thus, refolding methods are designed to suppress the side 
reaction of (3). 
 
 By contrast, heat-induced inactivation is shown in (Fig. 
5). Amine compounds prevent chemical degradation during 
heat treatment (Process (2) in Fig. 5). After the heat treat-
ment, an unfolded molecule refolds spontaneously into the 
native state and the other unfolded molecule forms an aggre-
gate. Moreover, the heat-induced aggregates of lysozyme 
possess higher β-sheet content than those of refolding-
induced aggregates, as quantified by Fourier-transform infra-
red (FT-IR) spectroscopy [90]. It is noted that intermolecular 
disulfide bond exchanges occurred during heat treatment; 
however, this is not a crucial step when protein concentration 
is ≤ 1 mg/ml. 
 
 
 
Fig. (5). Heat-induced inactivation and aggregation of protein. 
First, protein is thermally unfolded at high temperature (UT). Dur-
ing the heat treatment of (1), the unfolded molecule gradually de-
grades chemically and structurally (D) during process (2). Subse-
quently, the samples are cooled down to room temperature (UC). 
The UC molecules are immediately refolded into the native state (N) 
or an irreversible aggregate (A). The solution additive affects the 
suppression of the processes (2) and (4). It is thought that amine 
compounds prevent chemical inactivation in the process of (2), 
while Arg mainly prevents the aggregation process of (4). 
 
 The difference between amine compounds (typically 
spermidine), Arg, and guanidine has been systematically 
investigated for refolding yield and for the heat-induced in-
activation of lysozyme as a model [90]. The following re-
sults obtained were clear: 1) Guanidine and Arg increase the 
solubility of reduced and carboxymethylated (RCM)-
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lysozyme, while spermidine does not; 2) spermidine sup-
presses the heat-induced inactivation and aggregation of 
lysozyme; and 3) guanidine and Arg increase the refolding 
yield of lysozyme. These data support the following hy-
pothesis: guanidine and Arg primarily increase the solubility 
of an aggregation-prone molecule, leading to the prevention 
of the irreversible inactivation of proteins (process (4) in Fig. 
5). On the other hand, spermidine primarily suppresses the 
chemical modifications of proteins caused by heat treatment 
(process (2) in Fig. 5), leading to the suppression of the heat-
induced inactivation of proteins. 
 Furthermore, five kinds of amino acids (Arg, Lys, Glu, 
Ser, and citrulline) and their derivatives have been investi-
gated for clarifying the indispensable chemical structure of 
additives for refolding and heat treatment [9]. The additives 
that prevent refolding-induced aggregation possess guanid-
ium or ureido groups (Fig. 6). Guanidine and urea are known 
as protein denaturants. These kinds of chemicals are bound 
to the hydrophobic surface that solubilizes aggregation-prone 
molecules, which indirectly increases the refolding yield of 
proteins as the aggregation suppressor. On the other hand, 
the additives that prevent heat-induced inactivation possess a 
principal amino acid chain (Fig. 6). This is because the heat-
induced inactivation mainly results from the chemical modi-
fications of proteins. It is interesting to note that the suppres-
sive effect of Arg on heat-induced aggregation of α -
chymotrypsin retains constant when temperature different 
from 65°C to 85°C, while that of a small poly(ethylene gly-
col) of tetraethylene glycol (TEG) increases with increasing 
temperature [91]. This results from the increase in hydro-
phobic interaction between TEG and unfolded protein with 
increasing temperature. 
2. CELLULAR AMINES 
 Finally, we would like to mention amine compounds in 
living cells. Spermine, spermidine, and putrescine are uni-
versally distributed in all living materials [92]. Cellular poly-
amines electrostatically bind to negatively charged macro-
molecules, typically DNA and RNA; hence, they stabilize 
(or destabilize) their tertiary structure. The nonspecific bind-
ing to the negative region of polyamines on macromolecules 
are involved in many cellular functions, such as cell growth, 
survival, proliferation, metabolism regulation, drag response, 
and diseases [93, 94]. These compounds in vivo may prevent 
the chemical degradation of proteins [11] as well as the deg-
radation of DNA and RNA. Their function to prevent the 
chemical degradation of macromolecules serves to remind us 
that organic solute “osmolyte” in living cells exists in an 
extreme environment [95]. The osmolytes reduce the struc-
tural and functional damages of macromolecules under 
stressful condition, such as trimethylamine-N-oxide, taurine, 
β-alanine, polyols, and sugars. It should be pointed out that 
these chemicals are amine compounds. The osmolytes play 
an important role in the extreme environment that resists 
osmotic water stress on macromolecules. Furthermore, these 
osmolytes may facilitate the prevention of chemical damage 
in living cells. 
 Hyperthermophiles exist in an environment at a tempera-
ture > 85°C; hence, hyperthermophilic proteins should have 
high conformational stability under high temperature as 
compared with that of their mesophilic counterpart proteins 
[96-98]. In general, high temperature accelerates the chemi-
cal reaction [99]. Thus, it is known that the amino acid com-
position of a hyperthermophilic protein is different from that 
of its mesophilic counterpart; moreover, Asn, Gln, Cys, and 
Met in hyperthermophilic proteins occur at lower contents 
than in mesophilic proteins [100, 101]. Although the tertiary-
folded state of protein is characterized by a higher tolerance 
of deamidation than the disulfide-reduced and protease-
digested state peptide [99], these heat-labile amino acids are 
also degraded by such high temperature environment. It is 
noted that hyperthermophiles have unique polyamines in the 
cells [102-105]. Thus, polyamines may prevent the thermal 
degradation of thermophilic proteins under extreme conditions.  
 
 
Fig. (6). Typical additives for refolding and heat-induced inactivation of lysozyme. Additives for refolding have the guanidium or ureido 
group, whereas additives for heat-induced inactivation have an amino acid backbone. Thus, ArgEE is, for example, a favorable additive for 
both refolding and heating. 
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CONCLUSION 
 This review summarizes the amine compounds that pre-
vent the heat-induced inactivation of proteins by suppressing 
chemical modification. We practically recommend the amine 
co-solute (ex. 50 mM spermidine) in protein solutions when 
thermal degradation of proteins needs to be avoided. Note 
that chemical reaction depends on temperature. It is assumed 
by the Arrhenius equation that heat treatment at 90°C for 10 
min results in full inactivation (< 10%) compared with that at 
30°C for one day. Thus, from the application point of view, 
it is suggested that amine compounds completely prevent 
chemical degradation as a preservative additive under the 
condition of low protein concentration at neutral pH. The 
simple chemicals that are used as solvent additives will im-
prove protein purification, shipping, storage, and heat treat-
ment for biotechnology and pharmaceutics. 
LIST OF ABBREVIATIONS 
ArgHCl = Arginine monohydrochloride  
ArgEE = Arginine ethylester  
βLG = β-lactoglobulin  
FT-IR = Fourier-transform infrared  
GlyAd = Glycine amide  
GlyEE = Glycine ethylester  
Gdn = Guanidine  
τ1 = Half-life time of the enzyme activity  
τ2 = The time for deamidation of one Asn residue 
per a protein  
NMR = Nuclear magnetic resonance  
RCM = Reduced and carboxymethylated  
RNase A = Ribonuclease A  
SPR = Surface plasmon resonance  
TEG = Tetraethylene glycol  
τ3 = The time of β-elimination of 0.2 disulfide 
bond per a protein 
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